Hospital Universitari de Bellvitge -ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2023

  1. Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma

    Frontiers in Endocrinology, Vol. 13

2021

  1. Thyroid lobectomy in patients with differentiated thyroid cancer: an analysis of the clinical outcomes in a nationwide multicenter study

    Gland Surgery, Vol. 10, Núm. 1, pp. 678-689

2019

  1. Characteristics of professionalism of specialists and advantages of multidisciplinary teams in thyroid cancer: results of a national opinion survey

    Endocrinologia, Diabetes y Nutricion, Vol. 66, Núm. 2, pp. 74-82

  2. On professionalism in the management of thyroid tumors and multidisciplinary working groups (reply letter)

    Endocrinologia, Diabetes y Nutricion

  3. Results of a nationwide survey on multidisciplinary teams on thyroid cancer in Spain

    Clinical and Translational Oncology, Vol. 21, Núm. 10, pp. 1319-1326

2017

  1. Consensus on the management of advanced radioactive iodine-refractory differentiated thyroid cancer on behalf of the Spanish Society of Endocrinology Thyroid Cancer Working Group (GTSEEN) and Spanish Rare Cancer Working Group (GETHI)

    Clinical and Translational Oncology, Vol. 19, Núm. 3, pp. 279-287

  2. PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics

    Journal of Molecular Diagnostics, Vol. 19, Núm. 4, pp. 575-588

  3. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma

    Clinical and Translational Oncology, Vol. 19, Núm. 1, pp. 12-20

2016

  1. Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI)

    Clinical and Translational Oncology, Vol. 18, Núm. 8, pp. 769-775

2012

  1. Comments to SEOM clinical guidelines for the treatment of thyroid cancer

    Clinical and Translational Oncology

2011

  1. Treatment of thyroid cancer with the new oral agents

    Annals of Oncology